Pre-Market Top Gainers in the U.S.

2 min read | August 09, 2024 12:00 AM PDT | By Team Kalkine Media

Pre-Market Top Gainers in the U.S. — Image source: Shutterstock

Iteris, Inc. (NASDAQ:ITI)

Iteris, Inc. (ITI) is leading the pre-market gainers with a dramatic rise of 64.49%, bringing its share price to USD 4.28. This substantial increase suggests significant market enthusiasm for the company's solutions in intelligent transportation systems and smart mobility, which are becoming increasingly relevant as infrastructure technologies advance.

MGO Global Inc. (NASDAQ:MGOL)

MGO Global Inc. (MGOL) follows closely with a notable 45.65% pre-market gain, with shares trading at USD 3.70. This surge highlights strong investor confidence in the company's business prospects and potential advancements within its industry.

Nauticus Robotics, Inc. (NASDAQ:KITT)

Nauticus Robotics, Inc. (KITT) has also experienced a robust pre-market increase of 44.26%, pushing its price to USD 1.92. This gain reflects heightened interest in the company's innovative robotics solutions for the maritime industry, showcasing the growing appeal of advanced technology in underwater exploration and operations.

Doximity, Inc. (NYSE:DOCS)

Doximity, Inc. (DOCS) is seeing a solid pre-market gain of 30.40%, with its shares reaching USD 25.66. The increase indicates a favorable market reaction to the company's performance in the digital health sector, where its platform continues to attract attention for its impact on medical communications and healthcare efficiency.

QT Imaging Holdings, Inc. (NASDAQ:QTI)

QT Imaging Holdings, Inc. (QTI) rounds out the top gainers with a 30.00% rise, elevating its share price to USD 0.4750. This gain underscores growing investor interest in the company's medical imaging technologies, which are poised to make significant strides in diagnostic capabilities.

These pre-market movements illustrate a diverse range of sectors experiencing heightened investor activity, from advanced robotics and medical technology to digital health solutions. The early gains set the stage for potentially significant developments in today’s trading session.

PS: The data has been sourced from a paid data source as of 9th August 2024 at 08:38 am (GMT-4)

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.